A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2409-2413

  Shimoyama, Shouji ^a   Aoki, Fiumio ^a   Kojima, Jun Ichi ^a   Kaminishi, Michio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biochemical modulation; Chemoradiation; Esophageal cancer; Radiosensitizing effect

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

AGED; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; ESOPHAGUS CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE;

EID: 0032846040     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR: Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995; 19:198-204.
2. Earlam R, Cunha-Melo JR: Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67:381-390.
3. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H: Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77:845-857.
4. Coia LR, Engstrom PF, Paul A: Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987; 5:1783-1790.
5. Richmond J, Steydel HG, Bae Y, Lewis J, Burdakin J, Jacobsen G: Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987; 13:1617-1620.
6. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS, Padmanabhan A: Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989; 63:2397-2403.
7. Shirnoyama S, Konishi T, Kawahara M, Hojo K, Takeda Y, Nagayama T: Complete response of esophageal cancer achieved by combination therapy with 5-fluorouracil, low dose cisplatin, and radiation: Report of a case. Surgery Today 1998; 28:1163-1167.
8. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M: Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models ia vivo. Cancer Chemother Pharmacol 1993; 32:167-172.
9. Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T: Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 1996; 53:64-67.
10. Houghton JA, Schmidt C, Houghton PJ: The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts. Eur J Cancer Clin Oncol 1982; 18:347-354.
11. Scheithauer W, Depisch D, Kornek G, Pidlich J, Rosen H, Karall M, Prochaska M, Ernst A, Sebesta C, Echhardt S: Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer 1994; 73:1562-1568.
12. Japanese Society for Esophageal Disease: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 1976; 6:69-86.
13. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma. Tokyo: Kanchara, 1995.
14. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981; 47:207-214.
15. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study. J Clin Oncol 1989; 7:425-432.
16. Skov K, MacPhail S: Interaction of platinum drugs with clinically relevant X-ray doses in mammarian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 1991; 20:221-225.
17. Sun J-R, Brown JM: Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 1993; 133:252-256.
18. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG: Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993; 105:749-756.